Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

NCT06172205 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

262

Enrollment

OTHER

Sponsor class

Conditions

BCLC Stage C Hepatocellular Carcinoma
Chemotherapy Effect

Interventions

DRUG: intravenous FOLFOX7 plus Camrelizumab and apatinib
DRUG: HAIC-FOLFOX plus Camrelizumab and apatinib

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University